JANSSEN-CILAG LIMITED
Get an alert when JANSSEN-CILAG LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-29
Confirmation statement due
2027-01-24 (in 8mo)
Last made up 2026-01-10
Watchouts
None on the register
Cash
£3M
-85.6% vs 2023
Net assets
£248M
+23.3% vs 2023
Employees
1,090
-0.1% vs 2023
Profit before tax
£69M
-4.9% vs 2023
Name history
Renamed 1 time since incorporation
- JANSSEN-CILAG LIMITED 1995-01-01 → present
- JANSSEN PHARMACEUTICAL LIMITED 1971-10-19 → 1995-01-01
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-29
| Metric | Trend | 2023-12-31 | 2024-12-29 |
|---|---|---|---|
| Turnover | £653,218,000 | £637,412,000 | |
| Operating profit | £59,323,000 | £60,635,000 | |
| Profit before tax | £72,260,000 | £68,712,000 | |
| Net profit | £53,328,000 | £50,821,000 | |
| Cash | £19,483,000 | £2,797,000 | |
| Total assets less current liabilities | — | — | |
| Net assets | £201,071,000 | £247,832,000 | |
| Equity | £201,071,000 | £247,832,000 | |
| Average employees | 1,091 | 1,090 | |
| Wages | £141,614,000 | £135,339,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-29 |
|---|---|---|---|
| Operating margin | 9.1% | 9.5% | |
| Net margin | 8.2% | 8.0% | |
| Current ratio | 1.31x | 1.47x | |
| Interest cover | 3489.59x | 90.91x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The company has prepared the financial statements on a going concern basis. The Directors believe it is reasonable to assume that the Company will have adequate resources for a period of 12 months (the "Assessment Period") from the date of approval of these financial statements to discharge its obligations as they fall due. The Directors have a reasonable expectation that the Company has sufficient resources to continue in operational existence for the foreseeable future.”
Significant events
- “On October 1st 2025, the directors approved the dividends to its shareholders JJHC LLC and Johnson & Johnson International in the amount of GBP 98,000,000. There have been no other significant events affecting the Company since the year end requiring disclosure in the financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 38 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| BEKKER, Rozlyn | Director | 2023-03-29 | Aug 1978 | British,South African |
| DRAPER, Charlotte | Director | 2024-09-30 | Oct 1974 | English |
| FLEMING, John David, Dr | Director | 2024-03-15 | Oct 1978 | British |
| GOMEZ LORA, Maria Alexandra | Director | 2026-03-18 | Aug 1972 | Colombian |
| ILBERT, Robin John | Director | 2020-01-01 | Nov 1972 | British |
Show 38 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BUTTERWORTH, Barbara Susan | Secretary | — | 2015-08-28 |
| ROSE, Douglas Alfred Peter | Secretary | 2015-11-09 | 2018-06-29 |
| AERTS, Liesbeth | Director | 2018-08-01 | 2022-06-10 |
| ANDERSON, Shelagh Mary | Director | 2015-12-15 | 2025-12-30 |
| BARNES, Peter Mark Fraser, Dr | Director | 2007-02-05 | 2015-03-17 |
| CAINZOS FERNANDEZ, Jesus | Director | 1992-12-10 | 1999-01-28 |
| COHEN, Maurice, Dr | Director | — | 1992-03-11 |
| COOPER, Rozlyn | Director | 2016-01-07 | 2019-01-04 |
| DONNELLY, Robert John, Dr | Director | 1995-01-12 | 2006-05-05 |
| DRICKWOOD, David John | Director | 1994-07-07 | 1999-12-26 |
| FRASER, Shona | Director | 2020-01-01 | 2024-03-15 |
| GEELAN, David | Director | 2022-06-10 | 2026-01-09 |
| GOODWIN, Bruce Michael | Director | 2000-02-01 | 2003-05-26 |
| GRANEY, Thomas Nicholas | Director | 2003-06-09 | 2005-04-28 |
| HAMLIN, Angela June | Director | 2012-07-06 | 2017-02-28 |
| HICKEN, Mark Iain | Director | 2014-01-02 | 2019-04-01 |
| HODGES, Nicholas George | Director | 2018-02-19 | 2020-01-01 |
| INGHELBRECHT, Dominique Christelle | Director | 2016-05-01 | 2018-06-01 |
| JACKSON, David Cooper | Director | 1994-12-07 | 1997-10-15 |
| JANSSEN, Paul, Dr | Director | — | 1992-06-22 |
| KELLER, Philip Henry | Director | 1998-06-10 | 2000-01-01 |
| LAMBRECHTS, Frank | Director | 2013-01-02 | 2016-05-01 |
| LEBLAY, Gaetan | Director | 2019-04-01 | 2023-03-29 |
| MCDONALD, John | Director | 2000-01-01 | 2008-01-31 |
| NIJJAR, Harjinder | Director | 2005-04-28 | 2012-12-30 |
| PATROE, Vinay | Director | 2020-10-06 | 2023-09-29 |
| RODRIGUEZ VALDAJOS, César | Director | 2011-08-15 | 2013-12-27 |
| SAN MARTIN, Rodrigo Resende | Director | 2010-01-01 | 2011-06-15 |
| SHETTY, Sunangal Ajit | Director | 1995-09-13 | 2003-05-26 |
| SICKLEN, Clare | Director | 2017-03-01 | 2020-01-01 |
| SNAITH, Michael Emmerson | Director | — | 1994-07-07 |
| SOARES, Bernardo | Director | 2019-02-10 | 2020-03-09 |
| TANCA, Silvano Valentino | Director | 1992-06-22 | 2001-12-20 |
| VERBEECK, Christian | Director | 1999-01-28 | 2003-05-26 |
| VERCAUTEREN, Guido Alice Godfried | Director | — | 1992-12-10 |
| WIEGAND, Frank | Director | 2017-11-13 | 2018-08-01 |
| WOODING, Stephen James, Dr | Director | 2009-01-16 | 2009-12-23 |
| YOGENDRAN, Logesvaran, Dr | Director | 2015-12-15 | 2017-11-30 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Johnson & Johnson | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Active |
Filing timeline
Last 20 of 210 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-02 | AP01 | officers | Appoint person director company with name date | |
| 2026-01-16 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-01-09 | TM01 | officers | Termination director company with name termination date | |
| 2026-01-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-11-03 | AA | accounts | Accounts with accounts type full | |
| 2025-02-05 | AA | accounts | Accounts with accounts type full | |
| 2025-01-21 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-10-16 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-19 | AP01 | officers | Appoint person director company with name date | |
| 2024-03-19 | TM01 | officers | Termination director company with name termination date | |
| 2024-01-19 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-12-13 | TM01 | officers | Termination director company with name termination date | |
| 2023-10-23 | AA | accounts | Accounts with accounts type full | |
| 2023-04-12 | TM01 | officers | Termination director company with name termination date | |
| 2023-04-12 | AP01 | officers | Appoint person director company with name date | |
| 2023-01-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-10-24 | AA | accounts | Accounts with accounts type full | |
| 2022-10-05 | TM01 | officers | Termination director company with name termination date | |
| 2022-10-05 | AP01 | officers | Appoint person director company with name date | |
| 2022-01-10 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-29 vs 2023-12-31
-
Turnover
-2.4%
£653,218,000 £637,412,000
-
Cash
-85.6%
£19,483,000 £2,797,000
-
Net assets
+23.3%
£201,071,000 £247,832,000
-
Employees
-0.1%
1,091 1,090
-
Operating profit
+2.2%
£59,323,000 £60,635,000
-
Profit before tax
-4.9%
£72,260,000 £68,712,000
-
Wages
-4.4%
£141,614,000 £135,339,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers